COO of Arrowhead Pharmaceuticals Inc (30-Year Financial, Insider Trades) Bruce D Given (insider trades) sold 23,515 shares of ARWR on 04/20/2020 at an average price of $40 a share. The total sale was $940,600.
Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins. Arrowhead Pharmaceuticals Inc has a market cap of $3.76 billion; its shares were traded at around $36.94 with a P/E ratio of 69.68 and P/S ratio of 22.33. GuruFocus has detected 2 severe warning signs with Arrowhead Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- COO Bruce D Given sold 23,515 shares of ARWR stock on 04/20/2020 at the average price of $40. The price of the stock has decreased by 7.65% since.
- Director Douglas B Given sold 25,000 shares of ARWR stock on 04/14/2020 at the average price of $36.89. The price of the stock has increased by 0.14% since.
For the complete insider trading history of ARWR, click here
.
